Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO

Giovanni Scambia, Domenica Lorusso, P Harter, J Sehouli, A Reuss, A Hasenburg, D Cibula, S Mahner, I Vergote, A Reinthaller, A Burges, L Hanker, M Pölcher, C Kurzeder, U Canzler, Ku Petry, A Obermair, E Petru, B Schmalfeldt, A. Du Bois

Risultato della ricerca: Contributo in rivistaArticolo in rivista

170 Citazioni (Scopus)

Abstract

The DESKTOP I trial proposed a score for the prediction of complete cytoreduction in recurrent ovarian cancer. Resectability was assumed if 3 factors were present: (1) complete resection at first surgery, (2) good performance status, and (3) absence of ascites. The DESKTOP II trial was planned to verify this hypothesis prospectively in a multicenter setting.
Lingua originaleEnglish
pagine (da-a)289-295
Numero di pagine7
RivistaInternational Journal of Gynecological Cancer
Volume21
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Health Status Indicators
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms
  • Prospective Studies

Fingerprint Entra nei temi di ricerca di 'Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO'. Insieme formano una fingerprint unica.

Cita questo